Nerve Growth Factor

Dompé successfully engineered and manufactured the first recombinant human nerve growth factor (rhNGF) for the treatment of a rare corneal disease.


NETosis plays a master role in the development and progression of inflammation. Our cutting-edge research on this Platform focuses on understanding the immune response to the pathogenic challenges.


Our pipeline embraces the challenge in science, targeting some of the highest unmet medical needs.


Taking steps to positively impact people's lives requires expanding our understanding of science further and pursuing research and development in new and unexpected areas, with our team of world-class scientists.


We’re leveraging the most advanced intelligent supercomputing platform for drug screening to accelerate the discovery process – helping to deliver breakthrough treatment faster.